Shelter Pharma Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Shelter Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Shelter Pharma has secured an order from Taha Drugs & Chemicals Co., Sudan for Joemega Capsule and All Vitamins tablet, total order worth $ 1,44,000.

The company has appointed a Zonal Sales Manager for its veterinary division, along with a Regional Sales Manager for Uttarakhand and Western Uttar Pradesh. It has also added multiple sales officers across Gujarat and Rajasthan to enhance its field presence. In addition, an export executive has been appointed at the head office to support international business development.

According to the company, the appointments are part of its strategy to strengthen its sales hierarchy, improve operational efficiency, and expand market reach across regions. The move is also expected to support growth in export markets alongside domestic expansion.

Shelter Pharma is a pharmaceutical manufacturing company, specializing in herbal remedies for both human and veterinary healthcare.

The company?s standalone net profit jumped 27.12% to Rs 4.50 crore on 38.36% rise in net sales to Rs 33.29 crore in the half year ended September 2025 over the half year ended September 2024.

The order, valued at $18,300, is to be executed within six months, the company said in a regulatory filing.

The contract has been awarded by an international entity and is on a fixed-cost basis. Shelter Pharma added that neither the promoter nor the promoter group has any interest in the entity awarding the order.

The company also clarified that the transaction does not fall under related party transactions.

Shelter Pharma is engaged in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. Shelter is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio.

On a full year basis, the company?s standalone net profit jumped 16.8% to Rs 7.24 crore on 26.6% rise in net sales to Rs 50.66 crore in FY25 over FY24.

The scrip declined 0.34% to Rs 34.35 on the BSE.

Powered by Capital Market - Live News